Franziska Fries

5PUBLICATIONS
13CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 01, 2026
Discovery and Biosynthetic Characterization of Darumycins Expand the Chemical Space of Sesterterpene Antibiotics.

|Aug 10, 2026
The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis.

|Mar 19, 2026
Structure Elucidation, Biosynthesis and Biological Evaluation of Neosorangicin A, a Member of the Sorangicin Family.

Franziska Fries, Sebastian Walesch, Rolf Jansen

|Jan 22, 2025
YgiV promoter mutations cause resistance to cystobactamids and reduced virulence factor expression in Escherichia coli.

Timo Risch, Dominik Kolling, Dietrich Mostert

|Feb 24, 2024
Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791.

Franziska Fries, Andreas M Kany, Sari Rasheed

Pageof 1

Frequent Collaborators

3 joint publications

Rolf Müller

3 joint publications

Jennifer Herrmann

2 joint publications

Anna K H Hirsch

1 joint publications

Andreas M Kany